In 2019, Chan et al. conducted a similar study including 270 patients who were suspected to have GCA and received a TAB based on their elevated ESR (≥ 50 mm/h), CRP (20 mg/L), and/or platelet counts (300 × 109/L). This evidence concerns the gene CRP and temporal arteritis.